Condition
Heart Failure (HF)
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
22 shownNovel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial FibrillationNCT07436299 · 2026-09-01
RECRUITINGNon-Invasive Hemodynamic Monitoring in Hospitalized Heart FailureNCT07671742 · 2026-04-01
RECRUITINGEarly Detection and IntervenTion in Heart FailureNCT07731490 · 2025-12-03
RECRUITINGLeft Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After MyectomyNCT07372196 · 2025-11-14
RECRUITINGEffect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With HF and Their Caregivers: a Randomized Controlled TrialNCT06876441 · 2025-04-01
RECRUITINGDetecting the Undetected: Heart Failure Screening at the Lymphoedema Point of CareNCT07498868 · 2026-05-01
NOT_YET_RECRUITINGA Study on the Correlation Between Cardiac-Cerebral Oxygenation Reserve and Cognitive Function Changes in Heart Failure PatientsNCT07485816 · 2026-03-15
ENROLLING_BY_INVITATIONEvaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their CarersNCT07413419 · 2026-02-28
NOT_YET_RECRUITINGA Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real WorldNCT07141914 · 2025-08-29
COMPLETEDDiagnostic Electrical Cardioversion for Explaining Patient's AF and HF SymptomsNCT07000942 · 2025-08-01
NOT_YET_RECRUITINGEffects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation in Patients With Atrial FibrillationNCT07058987 · 2025-07-15
NOT_YET_RECRUITINGREsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)NCT05652218 · 2023-02-26
ACTIVE_NOT_RECRUITINGHEMOTAG® Assessment for Short-term Outcomes of Heart FailureNCT04149743 · 2022-01-31
UNKNOWNA Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HFNCT04915118 · 2021-06-17
COMPLETEDA Trial to Study BAY1753011 in Patients With Congestive Heart FailureNCT03901729 · 2019-05-29
COMPLETEDA Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.NCT03456856 · 2017-09-28
COMPLETEDPreoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）NCT06884436 · 2015-01-01
COMPLETEDSystematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT PatientsNCT02200822 · 2014-07-01
COMPLETEDSchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure RegisterNCT02301689 · 2014-05-01
COMPLETEDPhase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.NCT02127307 · 2014-02-01
COMPLETEDOpen-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.NCT01936649 · 2013-08-01
COMPLETEDClinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)NCT00811382 · 2008-05-01
TERMINATEDCommon interventions
AdreView (Iobenguane I 123 Injection)DRUG1BAY 1753011DRUG1beta blockersDRUG1BIV-CRTDEVICE1breathing trainingBEHAVIORAL1Cardiac Rehabilitation Combined With EECPBEHAVIORAL1Decompensation eventOTHER1dual-chamber ICDDEVICE1Electrical cardioversion (ECV)OTHER1FurosemideDRUG1HDTC training programBEHAVIORAL1Home Monitoring (Cardiac resynchronization therapy and atrial fibrillation therapy, with Home Monitoring feature)DEVICE1Home Monitoring (Cardiac resynchronization therapy and atrial fibrillation therapy, without Home Monitoring)DEVICE1ICD with left bundle branch area pacing (LBBAP)DEVICE1Intervention bundle comprising increased awareness, early diagnostics, and early treatment to improve HF prognosis.OTHER1IvabradineDRUG1LB-CRTDEVICE1No treatment givenOTHER1Placebo BAY 1753011OTHER1Placebo FurosemideOTHER1RAAS blockersDRUG1Remote Motivational InterviewingBEHAVIORAL1Routine Medical CareOTHER1Standard Heart Failure CareOTHER1Standard of Care with HemotagDIAGNOSTIC_TEST1
Leading sponsors
Bayer
2
GE Healthcare
2
Acorai AB
1
Amgen
1
Aventusoft, LLC.
1
Biotronik SE & Co. KG
1
Chinese PLA General Hospital
1
Hasselt University
1
Inova Health Care Services
1
Lanzhou University Second Hospital
1
M. Rienstra
1
Meshalkin Research Institute of Pathology of Circulation
1
Novo Nordisk A/S
1
Oslo University Hospital
1
ResMed
1
Trial status mix
COMPLETED9
RECRUITING5
NOT_YET_RECRUITING4
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
TERMINATED1
UNKNOWN1
Phase mix
NA9
PHASE43
PHASE21
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.